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Abstract
Background: Tuberculosis (TB) active case finding is a part of TB control in areas of higher TB prevalence.
Congested public transportation settings may be areas of increased TB transmission. We evaluated the uptake and
diagnostic yield of an active TB screening program among minibus drivers in a large public transportation facility in
Johannesburg, South Africa.
Methods: Over an eight month period, we intensively recruited minibus drivers for TB screening with a goal of
80% uptake among the estimated 2000 drivers. All participants were screened for TB symptoms, offered HIV testing,
and had sputum collected for smear microscopy and liquid culture.
Results: 686 drivers were screened for TB, representing an uptake of only 34% of all drivers (43% of the target
screening). Ten drivers (1.5%) were culture positive for TB, nine of whom were sputum smear microscopy negative.
Factors associated with previously undiagnosed TB included a history of incarceration (odds ratio [OR] 5.5, 95%
confidence interval: 1.1, 27.3) and HIV positivity (OR 5.3, 95% confidence interval: 1.1, 26.3).
Conclusions: We identified undiagnosed pulmonary TB cases among drivers but at a level that may be insufficient
to justify systematic case finding in this population considering the poor uptake.
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Background
Current approaches to tuberculosis (TB) control in low
and middle income countries with high HIV and TB
prevalence have achieved progress in reducing TB dis-
ease burden. However, prevalence and mortality rates
are not declining sufficiently to achieve global targets set
by the World Health Organisation (WHO) for 2015 [1].
This has been partly attributed to the challenge of early
identification of infectious cases [2], especially in places
or populations with poor access to health care, high
levels of undetected TB, or a high risk of transmission
[3,4]. These geographic or population-group clusters are
sometimes referred to as TB ‘hot spots’ or transmission
‘catalysts’. They may include specific congregate commu-
nities or occupational risk environments that result in
increased contact rates, exposure to highly infectious
TB, or increased susceptibility to TB disease [5]. Identifi-
cation of these settings, coupled with systematic targeted
active case finding (ACF) and treatment efforts may lead
to improved TB control [5].
In some situations, public transportation may serve as
a catalyst for TB transmission. Public transportation is
widely used in resource-limited-settings, especially among
individuals living in communities that may have a higher
prevalence of TB disease, including commuters from
informal or low cost housing at the periphery of cities
[6,7]. South Africa, which has among the highest preva-
lence of TB and HIV [2], and the fifth highest number of
undiagnosed active TB cases [1], also has a high degree of
dependence on public transportation. The majority of this
transportation is provided by minibuses characterized by
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limited airspace, overcrowding, and variable ventilation
[8]. Thus, minibuses may be places of increased TB trans-
mission. In particular, minibus drivers may be at especially
high risk of TB infection due to the confined airspace and
exposure to many potentially infectious passengers [9-11].
The high risk of TB exposure and infection, a possibility
of high levels of undetected TB, and long working
hours that may limit access to health care may warrant
implementation of ACF activities among minibus drivers.
As part of service delivery within a transport center in
central Johannesburg, South Africa, we provided walk-in
HIV counselling and testing (HCT) coupled with TB
screening to commuters and transport workers. Despite
high overall utilization of these services, only 225 drivers
(approximately 11% of the driver population) came for
TB screening during the first four years of this service
(unpublished Aurum data). The low uptake led to a
reassessment of how best to reach drivers with TB
screening. We decided to test a focused TB screening
program prior to a scaled-up implementation. Specifically,
we sought to provide a TB focused screening program for
transport workers to measure uptake and the diagnostic
yield of TB testing in a large transport center in central
Johannesburg, South Africa.
Methods
Study setting
We implemented a TB ACF program based at a routine
HCT and TB screening center in a transportation hub in
central Johannesburg, South Africa from August 2011 to
April 2012. The screening center was located in a space
within the transport hub that was easily accessible to
commuters and transport workers. The center served
approximately 100,000 short-distance commuters daily
who were traveling within greater Johannesburg and
near-by towns or informal settlements [12]. During the
study period, approximately 2,000 drivers operated daily
from the transport center.
The active case finding model
Prior to implementation of the ACF model, we obtained
stakeholder buy-in from the transport center manage-
ment, the 11 minibus associations operating within the
center, and nearby public health clinics. In addition, we
conducted focus group discussions with drivers to ex-
plore their perceptions regarding TB ACF and to iden-
tify ways to encourage TB screening. The formative
interviews identified three key issues: (1) TB screening
should be decoupled from HIV testing because drivers
unwilling to undergo HCT were interested in TB
screening, (2) TB screening needed to be brought to
the driver, and (3) the total time required for the
process needed to be short (<15 minutes).
We designed a program around these parameters. We
provided screening in portable gazebos in minibus
parking bays, limited the recipients of this service to
transport workers to keep waiting queues short (routine
HCT and TB screening was still available at the fixed
center site), and made HIV testing optional and available
at the end of the TB screening. The ACF team was
comprised of two nurses who led a team of four trained
lay counsellors. This team size allowed for screening 50
or more drivers during the main downtime in the
drivers’ day, between 9 am and 3 pm, each in less than
15 minutes. Drivers were mobilized for screening through
a combination of minibus association meetings, distribu-
tion of pamphlets, daily individual and group outreach,
and provision of vouchers for food or fuel (valued at
ZAR50/US$6).
TB screening was performed using the WHO four
symptom tool (any duration of cough, fever, night
sweats, or weight loss) [13]. In order to assess the sensi-
tivity of the symptom screen in this population, a single
spot sputum sample was collected from all drivers and
sent to a single commercial laboratory for fluorescence
microscopy and culture on mycobacterial growth indica-
tor tubes (MGIT, Becton, Dickenson, & Company, New
Jersey, USA).
Cultures that were positive for Mycobacteria species
were identified as M tuberculosis or a non-tuberculosis
mycobacteria species using Hain GenoType MTBDRplus
and the Hain GenoType Mycobacterium CM (Hain Life-
science GmbH, Germany). Positive cultures were tested
for drug susceptibility to first-line TB drugs using the
Becton Dickinson BACTEC MGIT SIRE system (Becton-
Dickinson, Franklin Lakes, USA). Participants were con-
tacted telephonically to collect their TB microscopy
results and when culture results were available. Individ-
uals who were positive for TB were educated on the
meaning of the test result and importance of treatment,
referred to a health facility, and followed-up to ascer-
tain entry into TB care.
All drivers were also offered HCT, but were not specif-
ically required to undergo HCT to be screened for TB.
HIV testing was done on-site using a rapid lateral flow
assay (Determine® HIV-1/2, Alere, Massachusetts, USA)
and, if positive, a confirmatory test was done using a
different rapid lateral flow assay (Unigold™ Recombigen®
HIV, Bray, Ireland). In addition, blood pressure screen-
ing and spot capillary blood glucose testing were offered
to all drivers (Roche Accucheck® Active Test Kit, Basel,
Switzerland).
Our goal was to screen 80% (1,600) of the minibus
drivers at the transport center. We planned on a three
month project period given the screening team capacity
and goal. However, we extended screening an additional
5 months (total 8 months) due to low uptake.
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Study design
We performed a cross-sectional assessment. All partici-
pants were administered a brief questionnaire that included
questions on demographics, working conditions, TB and
HIV testing history, TB knowledge, attitudes and beliefs
towards seeking health care, and current symptoms (any
duration of cough, fever, night sweats, or weight loss). All
participants completed a signed informed consent process
prior to study procedures. The study was approved by the
University of the Witwatersrand Human Subjects Ethics
Committee.
Analysis
We defined uptake by the total number of drivers screened
as a proportion of the total population of drivers working
at the transport center. Analyses of TB diagnosis were
restricted to definite TB, defined as a sputum culture
positive for M. tuberculosis. We excluded smear micros-
copy positive, culture negative TB from the analysis be-
cause of the limited specificity of a single sputum sample.
We defined elevated random glucose as a random capil-
lary blood glucose assay result of greater than 7.8 mmol/L
[14]. We used logistic regression to assess for associations
between undiagnosed prevalent TB and individual charac-
teristics including sex, age, HIV status, duration of work,
work hours, incarceration history, glucose level, and
current smoking status. Incarceration history was defined
as a participant reporting having spent at least one night
in a police holding cell or in a correctional service facility.
Multivariable logistic regression with backward elimin-
ation techniques was used for the final model. Retention
of study variables was based upon a Chi-squared p-value
of 0.05 or less.
Results
Participant characteristics and Uptake
From August 2011 to April 2012, 686 drivers were
screened for TB (all of them were part of the evaluation).
This represents an uptake of 34% (686/2000) of the
drivers who were using this transport hub and 43% of
the screening goal (686/1600). Among the 686 drivers,
684 (99.7%) were male with a median age of 37 years
(interquartile range [IQR] 30–45; Table 1). The majority
had worked at the transport center for more than a year
and most (94%) worked more than five days a week for a
median of 14 hours a day (IQR:13–15). They drove a
median of six round trips per day (IQR: 5–8) with each
leg of the trip averaging 30 to 60 minutes. At the time
of screening, the majority, 424 (62%), reported ever
having tested for HIV, while 406 (60%) agreed to HIV
testing. Of those tested for HIV during the study, 59 of
406 (15%) tested positive (Table 1). A further 19 (2.8%)
drivers who declined HCT reported a known HIV-
positive status.
TB screening results
We identified 10/686 (1.5%; 95% confidence interval [CI]:
0.7, 2.7) drivers with definite TB (Table 1), who were
previously unaware of their TB-infection status. All
specimens positive for TB were sensitive to isoniazid and
rifampin. Only one of the culture positive TB cases was
smear positive. A total of 186 (27%) drivers reported one
or more of the four TB symptoms. The sensitivity and
specificity of reporting one or more of the TB symptoms
when compared to sputum culture as the gold standard
was 80% (95% CI: 44, 96) and 74% (95% CI: 70, 77),
Table 1 Characteristics of minibus drivers participating in
an active TB screening program within in a large public
transport facility in Johannesburg, South Africa
N (%) or median (IQR)
Age, years 37 (30, 45)
Sex
Male 684 (99.7)
Female 2 (0.3)
Detention
Ever detained 254 (37)
Never detained 432 (63)
Current smoker
No 427 (62)
Yes 259 (38)
Ever diagnosed with TB 54 (8)
TB treatment
Currently receiving treatment 4 (1)
Ever received treatment 50 (7)
Never on treatment 632 (92)
Ever tested for HIV
Yes 424 (62)
No 262 (38)
Reported prior positive result 27 (6)
HIV testing at encounter
HIV testing performed 406 (60)
Tested HIV positive 59 (15)
Random glucose, mmol/L
<7.8 (normal) 547 (80)
7.8-11 (pre-diabetes) 93 (14)
>11 (diabetes) 40 (6)
TB symptom screening
Cough 139 (20)
Fever 33 (5)
Night sweats 72 (11)
Weight loss 49 (7)
Cough, fever, night sweats, or weight loss 186 (27)
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respectively. Three additional drivers were not included
among the TB cases; they were asymptomatic and had
smear microscopy positive and culture negative results.
An additional four drivers who were already diagnosed
with TB and on TB treatment at the time of screening
were not included among the TB cases.
Factors associated with TB disease
In assessing risk factors for newly diagnosed TB disease
we identified associations with the number of hours
worked per day, having HIV infection, a history of incar-
ceration, and currently smoking (Table 2). Elevated
random blood glucose and a report of prior TB disease
were not associated with a new TB diagnosis. In multi-
variable modelling, HIV infection (OR 5.3, 95% CI: 1.1,
26.3) and history of incarceration (OR 5.5, 95% CI: 1.1,
27.3) remained significantly associated with a new TB
diagnosis.
Discussion
We found a substantial number of minibus drivers with
pulmonary TB (1.5% with undiagnosed pulmonary TB).
Importantly, we also encountered a major challenge in
effectively engaging this population in ACF with an
uptake of only 34% (versus a target of 80%) of minibus
drivers.
The yield of TB diagnoses in our evaluation was ap-
proximately double that of a community-based mobile
screening campaign performed in Western Cape, South
Africa [15] but was less than that found in a larger
community-based representative sample from the same
region in South Africa in which 2.2% of adults were
found to have culture positive pulmonary TB [16]. Im-
portantly, our study was not a prevalence survey. We are
unable to comment on the actual prevalence of TB
among minibus drivers as we evaluated the feasibility of
TB screening in the population and neither used random
sampling nor achieved universal uptake.
We did not study factors associated with screening
uptake. However, informal discussions with participants
and non-participants during the course of the study
revealed that poor uptake may have partly been attribut-
able to the following: (1) fear of involuntary disclosure of
TB results that could lead to loss of employment or dis-
crimination within the workplace, (2) failure to see a bene-
fit in TB diagnosis because of the unavailability of on-site
TB treatment services, and (3) competing priorities for
time during the off-peak period targeted for screening.
Prior studies have suggested an increased risk of TB
disease among public transportation drivers and passen-
gers. A study from Peru reported increased TB disease
among commuters [11] and minibus drivers [10]. In
Table 2 Factors associated with TB disease among minibus drivers participating in an active TB screening program
within in a large public transport facility in Johannesburg, South Africa
†TB negative, N = 672 (%) TB Disease, N = 10 (%) Univariable odds ratio
(95% confidence interval)
p Multivariable odds ratio
(95% confidence interval)
p
Age
<35 292 (43.4) 3 (30.0) Referent *0.9 Referent *0.9
35-45 200 (29.8) 4 (40.0) 1.9 (0.4, 8.8) 1.7 (0.3, 8.3)
>45 180 (26.8) 3 (30.0) 1.6 (0.3, 8.1) 1.7 (0.3, 9.2)
Hours worked per day 14.2 (2.1) 15.4 (1.5) 1.5 (1.0, 2.2) 0.04 1.4 (0.9, 2.1) 0.07
HIV status
Negative 343 (51.0) 3 (30.0) Referent 1 Referent 1
Positive 55 (8.2) 4 (40.0) 8.3 (1,8, 38.2) 0.01 5.3 (1.1, 26.3) 0.03
Unknown 274 (40.8) 3 (30.0) 1.2 (0.3, 6.3) 0.8 1.0 (0.2, 5.2) 0.9
TB history
No prior TB 624 (92.9) 8 (80.0) Referent 1 - -
Prior TB 48 (7.1) 2 (20.0) 3.4 (0.7,16.5) 0.12 - -
Incarceration history
Never detained 427 (63.5) 2 (20.0) Referent 1 Referent 1
Ever detained 245 (36.5) 8 (80.0) 7.0 (1.5, 33.1) 0.02 5.5 (1.1, 27.3) 0.04
Current smoker
No 421 (62.7) 3 (30.0) Referent 1 Referent 1
Yes 251 (37.3) 7 (70.0) 3.9 (1.0, 15.3) 0.05 2.1 (0.5, 8.7) 0.3
*p value for trend.
†excludes four participants currently receiving treatment.
Mabuto et al. BMC Public Health  (2015) 15:242 Page 4 of 6
addition, a mathematical model, based on assumptions
from the South African context, predicted a 5% annual
risk of TB for minibus passengers, assuming 400 annual
trips per passenger [17]. It may be that the majority of
the risk comes from other passengers because, in our
study, the transport workers with TB were mostly
sputum smear negative and less likely to transmit TB.
Despite the possibility of a higher TB prevalence among
this population, the combination of limited smear posi-
tivity and the extensive effort that only succeeded in
screening a third of the drivers mean that screening
activities aimed toward this population may not be an
efficient use of resources.
The ten drivers with newly diagnosed TB worked
slightly longer hours, were more likely to be HIV infected,
and more likely to report a history of incarceration. HIV
infection and incarceration in correctional facilities are
both well documented to be associated with TB disease
[18,19]. It is unclear whether the trend between TB and
longer hours worked is due to increased contact with
passengers with untreated pulmonary TB or whether it is
confounded by other factors such as socio-economics.
Caution should be used in interpretation of the multivari-
able analysis due to few TB cases.
This study has the advantage that it was a real-world
implementation of TB ACF. As a result, we can describe
challenges and total uptake of services. This framework
introduces limitations on using the data for other pur-
poses. Importantly, we are unable to accurately calculate
the prevalence of TB in this population. It is unclear
whether TB prevalence and risk profiles were similar
among participants and non-participants. In addition,
we only screened those who were currently working
(screening occurred at the work place). Drivers missing
work as a result of TB disease and other illnesses were
not included (healthy worker effect). Furthermore, we
lacked data on drivers who did not accept TB screening;
thus we cannot compare characteristics between those
who did and did not opt for screening.
Conclusions
Ours is one of the few studies to assess TB screening
among transport workers. While we identified substan-
tial TB disease, it is unclear whether this differs from the
background population from which the drivers came.
Furthermore, willingness to be screened for TB was
poor, compromising TB prevention efforts. Other ap-
proaches to hot spot or catalyst identification and
screening may be more efficient for TB control than
screening minibus drivers in South Africa.
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